An emphasis Johnson & Johnson made at the start of 2018 on growing digital sales and a mid-year move into the natural supplements category were key drivers for its 3.2% consumer health sales growth for the year.
OTC drugs including Tylenol and Motrin analgesics, the Neutrogena and OGX beauty lines and the Listerine oral care brand drove...



